Search results for " progenitor cells."

showing 10 items of 56 documents

Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives

2015

Advanced knowledge in the field of stem cell biology and their ability to provide a cue for counteracting several diseases are leading numerous researchers to focus their attention on “regenerative medicine” as possible solutions for cardiovascular diseases (CVDs). However, the lack of consistent evidence in this arena has hampered the clinical application. The same condition affects the research on endothelial progenitor cells (EPCs), creating more confusion than comprehension. In this review, this aspect is discussed with particular emphasis. In particular, we describe biology and physiology of EPCs, outline their clinical relevance as both new predictive, diagnostic, and prognostic CVD b…

Pathologymedicine.medical_specialtyNeovascularization Physiologiclcsh:MedicineBone Marrow CellsReview ArticleRegenerative MedicineRegenerative medicineGeneral Biochemistry Genetics and Molecular BiologymedicineHumansSettore MED/05 - Patologia ClinicaCardiovascular diseases• regenerative medicine• endothelial progenitor cells• urgent standardization of EPC definition and characterization with precise criteriaProgenitor cellEndothelial Progenitor CellsConfusionGeneral Immunology and Microbiologybusiness.industrylcsh:RSettore MED/23 - Chirurgia CardiacaGeneral MedicineFocus (linguistics)Cardiovascular DiseasesEndothelium VascularVascular pathologymedicine.symptombusinessStem cell biologyNeuroscienceStem Cell Transplantation
researchProduct

Cardiac tissue engineering: a reflection after a decade of hurry

2014

The heart is a perfect machine whose mass is mainly composed of cardiomyocytes, but also fibroblasts, endothelial, smooth muscle, nervous, and immune cells are represented. One thousand million cardiomyocytes are estimated to be lost after myocardial infarction, their loss being responsible for the impairment in heart contractile function (Laflamme and Murry, 2005). The potential success of cardiac cell therapy relies almost completely on the ability of the implanted cells to differentiate toward mature cardiomyocytes. These cells must be able to reinforce the pumping activity of the injured heart in the absence of life-threatening arrhythmias due to electrophysiological incompatibility. Th…

Pathologymedicine.medical_specialtyheart regenerationPhysiologycardiac progenitor cellsClinical uses of mesenchymal stem cellsproto-tissueslcsh:PhysiologyTissue engineeringPhysiology (medical)MedicineInduced pluripotent stem cellStem cell transplantation for articular cartilage repairlcsh:QP1-981business.industryRegeneration (biology)Mesenchymal stem cellOpinion Articletissue engineeringscaffoldsStem cellbusinessNeurosciencecardiac progenitor cells proto-tissues heart regeneration tissue engineering scaffolds biomaterialsbiomaterialsAdult stem cell
researchProduct

Silk fibroin scaffolds enhance cell commitment of adult rat cardiac progenitor cells.

2015

The use of three-dimensional (3D) cultures may induce cardiac progenitor cells to synthesize their own extracellular matrix (ECM) and sarcomeric proteins to initiate cardiac differentiation. 3D cultures grown on synthetic scaffolds may favour the implantation and survival of stem cells for cell therapy when pharmacological therapies are not efficient in curing cardiovascular diseases and when organ transplantation remains the only treatment able to rescue the patient’s life. Silk fibroin-based scaffolds may be used to increase cell affinity to biomaterials and may be chemically modified to improve cell adhesion. In the present study, porous, partially orientated and electrospun nanometric n…

Sarcomeresprogenitor cellCell SurvivalCell Culture TechniquesBiocompatible MaterialsReal-Time Polymerase Chain ReactionZ-bodieMicroscopy Electron TransmissionCell AdhesionElectrochemistryAnimalsConnectinnatural polymermyocardial tissue; progenitor cells; Z-bodies; tissue engineering; natural polymers; silk fibroinTissue EngineeringTissue ScaffoldsMyocardiumStem CellsWaterCell Differentiationmyocardial tissueBombyxFlow CytometryExtracellular MatrixRatssilk fibroinMicroscopy Electron ScanningCollagenFibroinsPorosityJournal of tissue engineering and regenerative medicine
researchProduct

Tissue engineering: how to build a heart

2015

Decellularization and recellularization of hearts from newly dead donors is the latest fashion in cardiac tissue engineering. The first paper came out in 2008 in Nature Medicine (Ott et al., 2008), and news has been recently published in Nature again in July 2013 (Maher, 2013). Brendan Maher in this paper summarizes and comments on the latest important results on decellularization of a human heart and explains the steps that are necessary to build a heart from a decellularized organ. Two sources may be used to obtain a decellularized heart: human and pig heart. Another issue to resolve is the time of decellularization, since the detergents used may also destroy the architecture of the organ…

ScaffoldPathologymedicine.medical_specialtyDecellularizationbusiness.industryPhysiologyGeneral CommentaryStem CellsCellular differentiationcardiac progenitor cellsCardiac tissue engineeringcardiac tissue engineeringTissue engineeringstem cellsPhysiology (medical)Cardiac progenitor cellsMedicinedecellularizationImplantProgenitor cellStem cellbusinessInduced pluripotent stem cellNeuroscienceFrontiers in Physiology
researchProduct

Identification of mechanism(s) leading to hyperdiploidy in progenitor tumor cells derived from MCF7 breast cancer cells

2010

Stem cells are a minor population of mostly resting cells defined by their long life, high clonogenicity, self-replicating potential, plasticity, and drug resistance (Finn, 2008). Cells with these properties have been identified in various normal and cancerous human tissues (Wicha, 2006), as well as in several long-term tumor cell lines (Setoguchi, 2004). We have some preliminary data indicating that cells isolated from MCF7 line divide slowly and form spheres, both features of progenitors tumor cells, when grown in ultralow adherent plates and in absence of serum. Furthermore, these features were associated to two distinct populations characterized by different content in terms of number o…

Settore BIO/18 - Geneticamcf7 aneuploidy progenitor cells.
researchProduct

Endothelial Progenitor Cells A New Real Hope?

2017

Chronic inflammatory diseases, such as cardiovascular diseases (CVDs), diabetes, Alzheimer’s disease (AD) and cancer, have a disproportionate prevalence with advancing age owing to the continuous growth in the aging population. This condition determines several medical, economic and social problems due to the dramatic increase in the number of affected individuals, who are not autonomous. Thus, research efforts are centred around reducing and/or delaying the onset and progression of these diseases by researching new strategies for early prevention and diagnosis. In this context, understanding the mechanisms involved in the tissue, organ protection and repair are imperative for the developme…

Settore MED/05 - Patologia ClinicaEndothelial progenitor cells biomarkers therapeutic agents age-related diseases
researchProduct

In vitro differentiation of murine hematopoietic progenitor cells toward the myeloid lineage occurs in response to Staphylococcus aureus and yeast sp…

2013

We have studied the effect of inactivated microbial stimuli (Candida albicans, Candida glabrata, Saccharomyces boulardii, and Staphylococcus aureus) on the in vitro differentiation of lineage negative (Lin−) hematopoietic progenitor mouse cells. Purified Lin− progenitors were co-cultured for 7 days with the stimuli, and cell differentiation was determined by flow cytometry analysis. All the stimuli assayed caused differentiation toward the myeloid lineage. S. boulardii and particularly C. glabrata were the stimuli that induced in a minor extent differentiation of Lin− cells, as the major population of differentiated cells corresponded to monocytes, whereas C. albicans and S. aureus induced …

Staphylococcus aureusMyeloidLineage (genetic)FarmacologíaPattern-recognition receptorsCandida glabratamedicine.disease_causeMicrobiologyMicrobiologySaccharomycesCandida albicansmedicineAnimalsMouse hematopoietic progenitorsCandida albicansbiologyCandida glabrataCell DifferentiationFlow CytometryHematopoietic Stem Cellsbiology.organism_classificationCoculture TechniquesYeastIn vitroMice Inbred C57BLSaccharomyces boulardiiInfectious Diseasesmedicine.anatomical_structureStaphylococcus aureusReceptors Pattern RecognitionHematopoietic progenitor cellsFemaleMicrobial Pathogenesis
researchProduct

Comparison of growth & function of endothelial progenitor cells cultured on deproteinized bovine bone modified with covalently bound fibronectin …

2016

Objectives The objective of this study was to assess and compare the growth and function of Endothelial Progenitor Cells (EPCs) cultured on covalently bonded Vascular Endothelial Growth Factor (VEGF) and covalently bonded Fibronectin (FN) coating on deproteinized bovine bone (DBB) (test samples), compared to non-modified DBB blocks (control sample). Materials and methods The test samples were prepared by plasma polymerization of allylamine onto DBB blocks. Group1 of test samples were prepared with VEGF coating (VEGF-DBB) where as the Group2 test samples were coated with FN (FN-DBB). Non-modified DBB blocks served as a Control. EPCs were isolated and cultivated from buffy coats of peripheral…

Vascular Endothelial Growth Factor ANitric Oxide Synthase Type IIIAngiogenesis0206 medical engineeringNitric Oxide Synthase Type IICell CountEnzyme-Linked Immunosorbent Assay02 engineering and technologyReal-Time Polymerase Chain ReactionCell morphologyAllylamine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEnosAnimalsHumansMTT assayProgenitor cellCells CulturedCell ProliferationEndothelial Progenitor CellsMicroscopy Confocalbiology030206 dentistrybiology.organism_classification020601 biomedical engineeringMolecular biologyFibronectinsVascular endothelial growth factorFibronectinchemistryBone SubstitutesImmunologybiology.proteinCattleOral SurgeryClinical Oral Implants Research
researchProduct

Endothelial progenitor cells: Are they displaying a function in autoimmune disorders?

2016

Endothelial Progenitor Cells (EPCs) are bone marrow derived cells able to differentiate in mature endothelial cells (EC) contributing to the generation of new vessels, connecting to fibronectin, and forming colonies and/or colony forming units. Since circulating EPCs can be actively considered part of endothelial damage in several cardiovascular diseases and autoimmune disorders the possibility to have a measure for endothelium damage should be considered of interest to predict the patient out-come. At the same time the EPCs proliferative and regenerative role could be considered for therapeutic applications. Studies have been performed to elucidate the role of EPCs in Systemic Sclerosis an…

Vasculitis0301 basic medicineVasculitiAgingEndotheliumAutoimmune Diseases03 medical and health sciences0302 clinical medicineMedicineAnimalsHumansRheumatoid arthritisProgenitor cellRheumatoid arthritiEndothelial Progenitor Cells030203 arthritis & rheumatologyColony-forming unitScleroderma SystemicbiologyEPCs; LES; Rheumatoid arthritis; Vasculitis; Aging; Developmental Biologybusiness.industryEPCmedicine.diseaseFibronectinSettore MED/16 - Reumatologia030104 developmental biologymedicine.anatomical_structureLESEPCsImmunologyembryonic structuresbiology.proteincardiovascular systemBone marrowEndothelium VascularbusinessVasculitisFunction (biology)circulatory and respiratory physiologyDevelopmental BiologyMechanisms of ageing and development
researchProduct

Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mous…

2013

The t(8;21) chromosomal translocation activates aberrant expression of the AML1-ETO (AE) fusion protein and is commonly associated with core binding factor acute myeloid leukaemia (CBF AML). Combining a conditional mouse model that closely resembles the slow evolution and the mosaic AE expression pattern of human t(8;21) CBF AML with global transcriptome sequencing, we find that disease progression was characterized by two principal pathogenic mechanisms. Initially, AE expression modified the lineage potential of haematopoietic stem cells (HSCs), resulting in the selective expansion of the myeloid compartment at the expense of normal erythro- and lymphopoiesis. This lineage skewing was foll…

cancer stem cellsCancer stem cells; Core binding factor acute myeloid leukaemia; Preclinical mouse model; Therapy target validation; Whole transcriptome sequencingMyeloidtherapy target validationOncogene Proteins FusionCloseupsBiologyGranulocyte-Macrophage Progenitor CellsTranslocation Geneticwhole transcriptome sequencingImmunophenotypingMiceGranulocyte-Macrophage Progenitor CellsCancer stem cellhemic and lymphatic diseasesmedicineAML1-ETOAnimalsCell Lineageacute myeloid leukaemiaLymphopoiesisProgenitor cellt(8;21)Research Articlespreclinical mouse modelGeneticsRegulation of gene expressionAntibiotics AntineoplasticSequence Analysis RNAcore binding factor acute myeloid leukaemiainducible mouse-modelHematopoietic Stem CellsMice Inbred C57BLDisease Models AnimalLeukemia Myeloid AcuteHaematopoiesisPhenotypemedicine.anatomical_structureGene Expression RegulationDoxorubicinCancer researchNeoplastic Stem CellsMolecular MedicineStem cell
researchProduct